A non-conservative polymorphism in the IL-6 signal transducer (IL6ST)/gp130 is associated with myocardial infarction in a hypertensive population

Regulatory Peptides

Volumn 146, Issue 1-3, 2008, Pages 189-196

  Benrick, Anna ^a   Jirholt, Pernilla ^b   Wernstedt, Ingrid ^a   Gustafsson, Maria ^b   Scheller, Juergen ^d   Eriksson, Anna Lena ^c   Borén, Jan ^b   Hedner, Thomas ^c   Ohlsson, Claes ^c   Härd, Torleif ^a   Rose John, Stefan ^d   Jansson, John Olov ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

gp130; Interleukin 6 signal transducer (IL6ST); Myocardial infarction; Single nucleotide polymorphisms (SNPs)

Indexed keywords

ARGININE; GLYCINE; GLYCOPROTEIN GP 130; INTERLEUKIN 6; STAT3 PROTEIN;

ADULT; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GENE STRUCTURE; GENETIC CONSERVATION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; HUMAN CELL; HYPERTENSION; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RISK FACTOR; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UNIVARIATE ANALYSIS;

ADULT; AGED; CELLS, CULTURED; COMORBIDITY; CYTOKINE RECEPTOR GP130; FEMALE; HUMANS; HYPERTENSION; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 38149030116     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2007.09.031     Document Type: Article

References (43)

1. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
2. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
3. Laberge M.A., Moore K.J., and Freeman M.W. Atherosclerosis and innate immune signaling. Ann Med 37 (2005) 130-140
4. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
5. Libby P., and Ridker P.M. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 116 Suppl 6A (2004) 9S-16S
6. Boulanger M.J., and Garcia K.C. Shared cytokine signaling receptors: structural insights from the gp130 system. Adv Protein Chem 68 (2004) 107-146
7. Hirota H., Chen J., Betz U.A., Rajewsky K., Gu Y., Ross Jr. J., et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97 (1999) 189-198
8. Kallen K.J. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim Biophys Acta 1592 (2002) 323-343
9. Uozumi H., Hiroi Y., Zou Y., Takimoto E., Toko H., Niu P., et al. gp130 plays a critical role in pressure overload-induced cardiac hypertrophy. J Biol Chem 276 (2001) 23115-23119
10. Rodriguez C., Theillet C., Portier M., Bataille R., and Klein B. Molecular analysis of the IL-6 receptor in human multiple myeloma, an IL-6-related disease. FEBS Lett 341 (1994) 156-161
11. Escobar-Morreale H.F., Calvo R.M., Villuendas G., Sancho J., and San Millan J.L. Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism. Obes Res 11 (2003) 987-996
12. I. Fischer M., Goldschmitt J., Peschel C., Brakenhoff J.P., Kallen K.J., Wollmer A., et al. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol 15 (1997) 142-145
13. Schroers A., Hecht O., Kallen K.J., Pachta M., Rose-John S., and Grotzinger J. Dynamics of the gp130 cytokine complex: a model for assembly on the cellular membrane. Protein Sci 14 (2005) 783-790
14. Ymer S., Tucker W.Q., Sanderson C.J., Hapel A.J., Campbell H.D., and Young I.G. Constitutive synthesis of interleukin-3 by leukaemia cell line WEHI-3B is due to retroviral insertion near the gene. Nature 317 (1985) 255-258
15. Wahlfors J.J., and Morgan R.A. Production of minigene-containing retroviral vectors using an alphavirus/retrovirus hybrid vector system. Hum Gene Ther 10 (1999) 1197-1206
16. Hibi M., Murakami M., Saito M., Hirano T., Taga T., and Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63 (1990) 1149-1157
17. Hansson L., Lindholm L.H., Niskanen L., Lanke J., Hedner T., Niklason A., et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 353 (1999) 611-616
18. Prince J.A., Feuk L., Howell W.M., Jobs M., Emahazion T., Blennow K., et al. Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. Genome Res 11 (2001) 152-162
19. Staiger H., Staiger K., Stefan N., Wahl H.G., Machicao F., Kellerer M., et al. Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. Diabetes 53 (2004) 3209-3216
20. Jougasaki M., Larsen A.M., Cataliotti A., Christiansen D.C., and Burnett Jr. J.C. Cardiotrophin-1 stimulates endothelin-1 via gp130 in vascular endothelial cells. Peptides 23 (2002) 1441-1447
21. Bouallegue A., Daou G.B., and Srivastava A.K. Endothelin-1-induced signaling pathways in vascular smooth muscle cells. Curr Vasc Pharmacol 5 (2007) 45-52
22. Yoshida K., Taga T., Saito M., Suematsu S., Kumanogoh A., Tanaka T., et al. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A 93 (1996) 407-411
23. Peters R.J., and Boekholdt S.M. Gene polymorphisms and the risk of myocardial infarction-an emerging relation. N Engl J Med 347 (2002) 1963-1965
24. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25 (2000) 187-191
25. Kiechl S., Lorenz E., Reindl M., Wiedermann C.J., Oberhollenzer F., Bonora E., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347 (2002) 185-192
26. Swanberg M., Lidman O., Padyukov L., Eriksson P., Akesson E., Jagodic M., et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 37 (2005) 486-494
27. Helgadottir A., Manolescu A., Thorleifsson G., Gretarsdottir S., Jonsdottir H., Thorsteinsdottir U., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36 (2004) 233-239
28. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376
29. Terry C.F., Loukaci V., and Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275 (2000) 18138-18144
30. Bennermo M., Held C., Stemme S., Ericsson C.G., Silveira A., Green F., et al. Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases?. Clin Chem 50 (2004) 2136-2140
31. Yang X., Jansson P.A., Pellme F., Laakso M., and Smith U. Effect of the interleukin-6 (-174) g/c promoter polymorphism on adiponectin and insulin sensitivity. Obes Res 13 (2005) 813-817
32. Humphries S.E., Luong L.A., Ogg M.S., Hawe E., and Miller G.J. The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22 (2001) 2243-2252
33. Georges J.L., Loukaci V., Poirier O., Evans A., Luc G., Arveiler D., et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde. J Mol Med 79 (2001) 300-305
34. Chiappelli M., Tampieri C., Tumini E., Porcellini E., Caldarera C.M., Nanni S., et al. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet 32 (2005) 349-353
35. Kelberman D., Hawe E., Luong L.A., Mohamed-Ali V., Lundman P., Tornvall P., et al. Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study. Thromb Haemost 92 (2004) 1122-1128
36. Lieb W., Pavlik R., Erdmann J., Mayer B., Holmer S.R., Fischer M., et al. No association of interleukin-6 gene polymorphism (-174 G/C) with myocardial infarction or traditional cardiovascular risk factors. Int J Cardiol 97 (2004) 205-212
37. Sie M.P., Sayed-Tabatabaei F.A., Oei H.H., Uitterlinden A.G., Pols H.A., Hofman A., et al. Interleukin 6-174 g/c promoter polymorphism and risk of coronary heart disease: results from the Rotterdam study and a meta-analysis. Arterioscler Thromb Vasc Biol 26 (2006) 212-217
38. Chapman C.M., Beilby J.P., Humphries S.E., Palmer L.J., Thompson P.L., and Hung J. Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian community population. Eur Heart J 24 (2003) 1494-1499
39. Jerrard-Dunne P., Sitzer M., Risley P., Steckel D.A., Buehler A., von Kegler S., et al. Interleukin-6 promoter polymorphism modulates the effects of heavy alcohol consumption on early carotid artery atherosclerosis: the Carotid Atherosclerosis Progression Study (CAPS). Stroke 34 (2003) 402-407
40. Kubaszek A., Pihlajamaki J., Komarovski V., Lindi V., Lindstrom J., Eriksson J., et al. Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 52 (2003) 1872-1876
41. Wernstedt I., Eriksson A.L., Berndtsson A., Hoffstedt J., Skrtic S., Hedner T., et al. A common polymorphism in the interleukin-6 gene promoter is associated with overweight. Int J Obes Relat Metab Disord 28 (2004) 1272-1279
42. Wallenius V., Wallenius K., Ahren B., Rudling M., Carlsten H., Dickson S.L., et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8 (2002) 75-79
43. Koradi R., Billeter M., Wuthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 1996;14:51-55, 29-32.